New device may predict kidney recovery in ICU patients
NCT ID NCT02812784
First seen Jun 12, 2026 · Last updated Jun 20, 2026 · Updated 1 time
Summary
This study tested whether the Nephrocheck™ device can predict if early acute kidney injury will reverse within 72 hours in patients with septic shock. Researchers enrolled 184 adults in the ICU and measured the device's accuracy. The goal is to help doctors decide who might recover without aggressive treatments like dialysis.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEADING are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
CH Avranches-Granville
Avranches, 50300, France
-
CH Cahors
Cahors, 46000, France
-
CH Dax
Dax, 40100, France
-
CH Marc Jacquet
Melun, 77000, France
-
CH Paris-Saint Joseph
Paris, 75, France
-
CH Salon-de-provence
Salon-de-Provence, 13300, France
-
CH de Mont-de-Marsan
Mont-de-Marsan, 40000, France
-
CHU Amiens
Amiens, 80054, France
-
CHU Montpellier
Montpellier, 34172, France
-
CHU Poitiers
Poitiers, 86000, France
-
CHU Saint-Etienne
Saint-Etienne, 42000, France
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Nephrocheck™ device
What this could lead to
If successful, this could help doctors quickly identify which patients with septic shock will recover kidney function without needing dialysis.
What could go wrong
This is a completed study with 184 participants, so results are available but may not apply to all patients. The device is a diagnostic tool, not a treatment, so it won't directly improve outcomes.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.